Skip to main content
OpenTrials
Recruiting

NCT Number: NCT02357654

GnRH for Luteal Support in IVF/ICSI/FET Cycles

During IVF cycles an embryo is generally placed into the uterine cavity between 3 and 5 days after fertilization. For a successful pregnancy to take place, that embryo must then implant in the properly primed and staged endometrium, which subsequently must continue to develop to accommodate the growing and maturing embryo and then fetus. This process is normally regulated by hormonal interactions between the fetal, endometrial and luteal tissue. It has been found that after IVF additional support for the endometrium with progesterone improves implantation and subsequent live birth rates in IVF cycle . Recent data has shown that additional supplementation with a single administration of a GnRH agonist around the time the time of embryo transfer may further enhance these rates .

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–40 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Primary location

University Reproductive Associates

Hasbrouck Heights, New Jersey, 07604, United States

Location status: Recruiting

Location contact

Peter G. McGovern, MD

PRINCIPAL_INVESTIGATOR

About this study

see above

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • women undergoing IVF/ICSI or frozen embryo transfers (FET) that less than 40 years old.

Exclusion criteria

  • day 3 transfers

Treatment and study plan

GnRH

Drug

single shot of GnRH agonist

Placebo

Drug

placebo

Primary outcomes

  1. Live birth per transfer

    Time frame: 9 months

Secondary outcomes

  1. implantation rates

    Time frame: 4 weeks

  2. clinical pregnancy

    Time frame: 4 weeks

  3. rates of OHSS

    Time frame: 4 weeks

Study contacts

Contact information is provided by the study sponsor or research team.

Peter G McGovern, MD

CONTACT

[email protected]

201-288-6330

Sponsors and collaborators

Lead sponsor

University Reproductive Associates

Other

Registry information

Important dates

Study start
2015
Primary completion
2026
Study completion
2026
First posted
Feb 6, 2015
Registry last updated
Jul 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.